En + Cy
Resetpotential.
A new direction in neuroplastogens
Ensysce Biosciences and Cy Biopharma have come together to create a clinical-stage company with a lead rare-pain program focused on a neural reset.
One company. Two powerful approaches.
Our breakthrough technologies—including a new class of botanical psychedelic molecule—tackle the most challenging cases of complex and severe pain, aiming for safer treatment with durable relief.
We work with nature to enhance nature. Our therapeutics go beyond relieving symptoms to activate serotonin receptors and boost neuroplasticity, increasing strength, resilience and the body’s innate restorative intelligence—and reducing the potential for misuse.
Your portal
to possibility.
What’s on the other side of pain?
Everything. Resilience, movement, connection, experience, sleep, yourself.
Life.